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ABSTRACT
Background. Periodontitis is associated with increased concentration of inflammatory
markers and saliva has been proposed as a non-invasive diagnostic fluid in oral
and systemic diseases. The levels of salivary biomarkers, such as cytokines, could
potentially be used to distinguish periodontal healthy individuals from subjects with
periodontal disease. The purpose of this study was to characterize the salivary levels
of two inflammatory biomarkers associated with periodontitis, interleukin-6 (IL-6)
and tumour necrosis factor-alpha (TNF-α), in order to assess whether these cytokines
salivary levels could potentially be used to complement periodontitis pregnant women
diagnose.
Methods. Forty-four pregnant women were distributed into three groups, according to
their periodontal status: healthy, mild/moderate periodontitis and severe periodontitis.
Unstimulated saliva was collected and analysis of TNF-α and IL-6 salivary levels were
performed with Immulite R©.
Results. Women with periodontitis exhibited significantly higher levels (p= 0.001) of
salivary IL-6 and TNF-α compared with the healthy group: 25.1 (±11.2) pg/mL vs.
16.3 (±5.0) pg/mL and 29.7 (±17.2) pg/mL vs. 16.2 (±7.6) pg/mL, approximately 1.5
and 1.8 times more, respectively. Additionally, cytokines were significantly increased
(p< 0.05) in severe periodontitis compared to periodontal healthy pregnant women.
Conclusions. These results revealed that IL-6 and TNF-α salivary biomarkers provide
high discriminatory capacity for distinguishing periodontal disease from periodontal
health in pregnant women.
Subjects Dentistry, Epidemiology, Immunology, Nursing
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INTRODUCTION
Periodontal diseases continue to be a major public health problem worldwide, but there
is evidence that the initiation, progression and severity does not affect all people in the
same way (Dye, 2012; Petersen & Ogawa, 2012; Baelum & López, 2013; Persson, 2017).
Some epidemiological studies have demonstrated that gingival inflammation affects 60 to
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75% of pregnant women (Loe & Silness, 1963; Silness & Löe, 1964; Tilakaratne et al., 2000;
Michalowicz et al., 2008; Ho & Chou, 2016), although not all present the same gingival
inflammatory pattern and the symptoms can range from mild inflammation to severe
hyperplasia, pain and profuse bleeding.
There is evidence that support a causal relationship between inflammation and
spontaneous preterm labour (Romero et al., 2006), but the exact etiology of pregnancy
gingivitis is still unknown. Some studies demonstrate that the increase of female sexual
hormones’ serum concentration during gestation, may lead to gingivitis gestation (Brabin,
1985; Gürsoy et al., 2010). Further, host immune and inflammatory responses play a
major role in periodontitis (González-Jaranay et al., 2017) and some cytokines genes were
suggested to influence the development of periodontal disease (D’Aiuto et al., 2004; Ebersole
et al., 2016; Kinane, Stathopoulou & Papapanou, 2017). Also, when compared to healthy
patients, subjects with gingivitis or periodontitis produce high levels of inflammatory
mediators, such as IL-6 and TNF-α (Zhu et al., 2016).
Saliva, as a pooled sample, contains specific biomarkers for unique pathological aspects
of periodontal disease, such as interleukin-1β (IL-1β), IL-6, IL-8, IL-11 and tumor necrosis
factor-alpha (TNF-α) (Graves, 2008; Rathnayake et al., 2017). Recent studies suggested
that cytokine levels in this fluid might be linked with the periodontal status of the patient
(Jaedicke, Preshaw & Taylor, 2016; Belstrøm et al., 2017). Thus, qualitative changes in the
levels of these biomarkers could have diagnostic and therapeutic significance. Interleukin
6 (IL-6) is a pro-inflammatory cytokine associated with the severity of periodontitis
contributing to bone resorption (Moreira et al., 2007; Graves, 2008; Jaedicke, Preshaw &
Taylor, 2016; Zhu et al., 2016). TNF-α is a pro-inflammatory cytokine that has an effect
in the activation of inflammatory leukocytes, modification of vascular permeability and
induction of bone resorption (Assuma et al., 1998; Varghese et al., 2015) and is a main
inducer of IL-6 (Katz, Nadiv & Beer, 2001).
In the past, some studies demonstrated a correlation between IL-6 and TNF-α with
periodontal status of pregnant women in crevicular fluid and gingival tissue (Carrillo-
De-Albornoz et al., 2012; Otenio et al., 2012; Wu et al., 2016). However, there are no
investigations concerning the salivary levels of these biomarkers in pregnant women.
Therefore, the goal of this pilot investigation was to assess the salivary concentration of




This study was approved by a Portuguese state recognized Ethics Committee, from Garcia
de Orta Hospital (Ethical Application Ref: 06/2015) and was carried out in accordance
with the Helsinki Declaration of 1975 as revised in 2013. Written informed consent
was obtained from all participants prior to appointment. All data were registered on a
database specifically created for this purpose, where a coded number was attributed to
each participant. This was a cross-sectional study without study-defined medical or dental
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interventions. Patients with diagnosed pathological conditions were referred to receive
appropriate treatment.
Patient selection
This pilot study was conducted at the Obstetrics and Gynecology Departments of Garcia de
Orta Hospital (Almada, Portugal) over one month period (February 2015). Out of the 408
pregnant women that were being attended at those Departments, 82 (20%) were randomly
selected to participate. From those, taking into account the exclusion criteria, 44 (10.8%
of total) were enrolled in the study. Exclusion criteria were women with congenital uterine
and/or vaginal malformations, fetal malformation, multifetal gestation, chronic diseases
(e.g., diabetes, hypertension, epilepsy, cardiac disease, lung disease, renal disease, positive
test for human immunodeficiency virus (HIV)), history of systemic antibiotic treatment or
dental prophylaxis in the previous six months, and using systemic or topical antimicrobial
and/or anti-inflammatory therapy within the previous three months and smoking habit.
None of the women had received periodontal therapy before and during pregnancy.
Questionnaire
All women answered a questionnaire, to obtain information about their sociodemographic
status (age, marital status, education level, and occupation) and their personal oral hygiene
habits (frequency of tooth brushing and dental floss usage).
Educational level was assessed in two categories: basic/middle (1–12 years) and higher
(>12 years). Employment status of each participant was classified as: employed or
unemployed. Oral hygiene habits were assessed by information about toothbrush frequency
(one time daily, two or more times daily) and dental flossing.
TNF-α and IL-6 measurement in saliva
Unstimulated saliva samples were collected, by passive drooling, in a Falcon R© tube for
2 min, between 9:00 am and 11:00 am. Samples were frozen at the collection day and stored
at −80 ◦C until further analysis. The quantifications in whole unstimulated saliva were
performed according to Immulite R© (Siemens, Germany) manufacturer’s protocol and
assessed by a duplicate of each sample analyte. Both TNF-α and IL-6 were detected in all
samples. IL-6 and TNF-α levels were expressed in pg/mL.
Clinical examination
Each subject, who accepted to participate in the study, was assessed by an experienced
and calibrated examiner. Clinical examination was performed using a headlight with the
individuals seated on a regular chair in Garcia de Orta Hospital and required, on average,
45 min, without radiographic examination.
Periodontitis was defined as severe (individuals with≥ 2 interproximal sites with clinical
attachment loss (CAL) ≥ 6 mm, not on the same tooth and ≥ 1 interproximal sites with
probing depth (PD) ≥ 5 mm), moderate (individuals with ≥ 2 interproximal sites with
CAL≥ 4mm, not on the same tooth or≥ 2 interproximal sites with PD≥ 5mm, not on the
same tooth) and mild (≥ 2 interproximal sites with CAL ≥ 3 mm, and ≥ 2 interproximal
sites with PD ≥ 4 mm or one site with PD ≥ 5 mm) (Page & Eke, 2007).
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Table 1 Socio-demographic characteristics and oral health behaviors of subjects according to their
periodontal status.




n % n % n %
Education level
Basic/Middle 8 53.3 13 81.2 8 61.5
Higher 7 46.7 3 18.8 5 38.5
Marital status
Married 11 73.3 13 81.2 8 61.5
Single 4 26.7 3 18.8 5 38.5
Occupation
Employed 9 60.0 11 68.8 9 69.2
Unemployed 6 40.0 5 31.2 4 30.8
Toothbrush frequency
One time daily 1 6.7 3 18.8 2 13.6
Two or more
times daily
14 93.3 13 81.2 11 86.4
Dental floss usage
Yes 7 46.7 4 25.0 3 23.1
No 8 53.3 12 75.0 10 76.9
Data analysis
Data analysis was performed using IBM SPSS Statistics version 24.0 forWindows (Armonk,
NY: IBM Corp.). Descriptive statistics as frequencies, means and standard deviations were
calculated. Population means were estimated by calculating 95% confidence intervals (95%
CI). Inferential statistics methodologies (t -Student’s and ANOVA with Brown-Forsythe
correction tests) were used to compare both TNF-α and IL-6 data as a function of the
periodontal status. The level of significance was set at 5%.
RESULTS
The patient’s characteristics, according to the periodontal diagnosis, are shown in Tables 1–
3. No significant differences were found in socio-demographic and oral health behaviour
characteristics among the groups. In total, mean age was 32.4 years (±5.5) (range, 15–43
years) and the average gestation period was 25.4 weeks (range, 6–41 weeks). The majority
were in the second (43.2%) and third trimesters (40.9%) of pregnancy, and only 15.9%
were in the first-trimester.
Moreover, the education level showed similar numbers among healthy ones, but the
majority of pregnant women with mild/moderate or severe periodontitis had basic/middle
(81.2%, 61.5% respectively) education levels. The majority of participants were employed
(65.1%) and married (72.7%). Concerning the attitude and behaviour of pregnant women,
86.4% participants (n= 38) brushed their teeth twice or more a day and 68.2% were not
using interdental brushes and dental floss.
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Table 2 Distribution of cytokines salivary levels (pg/ml), presented as mean (±standard deviation)
and 95%CI for mean, for healthy and periodontitis subjects.
Inflammatory
cytokines (pg/mL)
Healthy (n= 15) Periodontitis (n= 29) p*
Mean (±SD) 95% CI Mean (±SD) 95% CI
TNF-α 16.3 (±5.0) [13.5–19.1] 25.1 (±11.2) [20.9–29.4] 0.001
IL-6 16.2 (±7.6) [12.0–20.5] 29.7 (±17.2) [23.2–36.3] 0.001
Notes.
*t -Student test.
Table 3 Distribution of cytokines salivary levels (pg/ml), presented as mean (±standard deviation) and 95%CI for mean, for healthy, mild/-
moderate and severe periodontitis groups.
Inflammatory
cytokines (pg/mL)





Mean (±SD) 95% CI Mean (±SD) 95% CI Mean (± SD) 95% CI
TNF-α 16.3 (±5.0)a [13.5–19.1] 24.3 (±12.5)a,b [17.6–30.9] 26.2 (±9.6)b [20.4–32.0] 0.020
IL-6 16.2 (±7.6)a [12.0–20.5] 27.1 (±18.4)a,b [17.3–36.9] 33.0 (±15.8)b [23.4–42.5] 0.016
Notes.
*ANOVA with Brown-Forsythe correction. Different lower case letters indicate significant differences between means in the same row (Games-Howell post-hoc test, p< 0.05).
The observed prevalence of periodontitis was 65.9% (95%CI [52.6–79.1%]). Specifically,
the prevalence of mild/moderate and severe periodontitis was 36.4% (95% CI [23.0–
49.8%]) and 29.5% (95% CI [16.8–42.2%]), respectively.
Descriptive statistics (mean and standard deviation) and 95% CI for means, of IL-6 and
TNF-α, for healthy and periodontitis groups, were calculated and are displayed in Table 2.
Mean salivary levels of IL-6 and TNF-α were significantly higher (p= 0.001) in subjects
with periodontitis than in healthy subjects: 25.1 (±11.2) vs. 16.3 (±5.0) pg/mL and 29.7
(±17.2) vs. 16.2 (±7.6) pg/mL, approximately 1.5 times and 1.8 times more, respectively.
Cytokine concentrations were significantly different between the healthy and different
periodontal status groups (Table 3). Salivary levels of IL-6 and TNF-α were significantly
increased (p< 0.05) in severe periodontitis compared to periodontal healthy group, but
were not found to be statistically significant among periodontitis groups.
DISCUSSION
The purpose of this pilot study was to evaluate salivary levels of IL-6 and TNF-α according
to periodontal status in pregnant women, in order to assess if the level of these pro-
inflammatory cytokines could potentially be used as complementary diagnostic in pregnant
women with periodontitis. The main finding was that periodontitis was associated with a
significant increase in salivary concentrations of all cytokines investigated when compared
with periodontal health pregnant women.
This cross-sectional pilot study assessed the periodontal status of forwarded pregnant
women subjects who were attended at Obstetrics and Gynecology Departments of Garcia
de Orta Hospital, that is located in the metropolitan area of Lisbon. To the best of our
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knowledge, this is the first investigation that associated periodontal status and cytokines
levels in a Portuguese women pregnant population.
Although our findings are somewhat limited by the small sample size and for being a
cross-sectional study, the selection criteria were very narrow and served to avoid potential
influence on cytokines levels, thus increasing the strength of the results. Furthermore,
it does not provide temporal relationship between exposure and outcome. Thus, in the
future we intend to perform a longitudinal study to clarify the periodontal effect and
complications on pregnancy.
Traditionally, periodontal diagnosis criteria includes plaque index, gingival index,
clinical attachment levels, probing depths, bleeding on probing, mobility of teeth, furcation
involvement and radiographic analysis (Page et al., 1997; Eke et al., 2015). However,
pregnant women are not recommended to do radiographic analysis and the diagnosis
with these criteria takes a long time. Additionally, these diagnostic parameters are excellent
on determining a past history of periodontal disease, however they do not evaluate the
inflammatory pattern of the ongoing disease and it is not possible to detect its onset or
progression. Saliva represents from whole mouth with all periodontal sites, thereby giving a
general assessment of periodontal disease. Thus, salivary cytokine levels have the potential
to reflect current activity, disease severity and possibly predict future disease progression,
and make aware of immediate or future treatment needs (Kaufman & Lamster, 2000;
Prasad, Tyagi & Aggarwal, 2015; Jaedicke, Preshaw & Taylor, 2016; Korte & Kinney, 2016;
Morand et al., 2017).
In this investigation, the periodontitis group showed higher salivary levels of IL-6
and TNF-α compared with periodontal healthy pregnant women. In detail, IL-6 and
TNF- α were only significantly increased in severe periodontitis compared to periodontal
healthy groups. Moreover, there were differences between mild/moderate and severe
periodontitis. These data are in accordance with previous findings where IL-6 and TNF-α
salivary concentrations were significantly elevated in periodontitis patients (Taba Jr et al.,
2005; Miller et al., 2006; Scannapieco et al., 2007; Frodge et al., 2008; Giannobile et al., 2009;
Ebersole et al., 2013). According to our results, IL-6 and TNF-α salivary levels appears to
have potential to distinguish pregnant women with and without periodontal disease.
CONCLUSIONS
Periodontally compromised pregnant women showed significantly higher IL-6 and TNF-α
salivary levels than healthy ones. These salivary biomarkers are likely to provide great
clinical benefit when supplemented with other clinical information. More studies are
needed with longitudinal methodology and larger samples to provide validated reference
values that distinguish periodontal disease from periodontal health, especially in initial
and developing phases, in order to predict the appearance and estimate the future disease
progress during pregnancy.
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